{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:58:54Z","timestamp":1793044734631,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"ABSTRACT<\/jats:title>\n \n Introduction:<\/jats:title>\n Transrectal ultrasound (TRUS) guided systematic prostate biopsy is conventionally used for the diagnosis of carcinoma prostate (CaP). However, magnetic resonance imaging (MRI) guided biopsies have been shown to have superior diagnostic performance. MRI-TRUS fusion biopsy improves the detection by combining the systematic and the targeted biopsies (TB). In this study, we evaluated the role of fusion biopsy in the detection of CaP as well as clinically significant carcinoma prostate (CsCaP).<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n In this retrospective study, the patients who underwent fusion biopsy from January 2016 to July 2022 were evaluated. Patients underwent multiparametric MRI and the suspicious lesions were reported as per the Prostate Imaging Reporting and Data System (PIRADS) version 2. The clinical, imaging, and biopsy parameters were recorded and evaluated.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n A total of 330 patients with PIRADS \u22653 underwent MRI-TRUS fusion biopsy and prostate cancer was detected in 187 patients (56.67%). With an increase in the PIRADS score, there was a significant rise in the detection of CaP (\n P<\/jats:italic>\n < 0.001) and CsCaP (\n P<\/jats:italic>\n < 0.0000001). Prostatitis was observed in 13%\u201318.1% of the patients with a lesion on MRI irrespective of the PIRADS score. The systematic and TB were comparable for the detection of CaP (\n P<\/jats:italic>\n = 0.88) and CsCaP (\n P<\/jats:italic>\n = 0.26). With a prostate-specific antigen density (PSAD) cutoff of 0.15 ng\/mL\/cc and 0.22 ng\/mL\/cc, biopsy could be safely avoided in 14.2% and 20.3% of the patients, missing only 0.3% of CaP and 0.9% of CsCaP, respectively. Different subgroups based on PSA levels, prostate volume, lesion dimension, and PIRADS score did not show a significant difference between the systematic and the targeted cores for the detection of CsCaP.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n This single center study of MRI-TRUS fusion prostate biopsy shows that in men with clinical suspicion of prostate cancer a pre-biopsy MRI and MRI-TRUS fusion combined systematic and targeted prostate biopsy improves the detection of prostate cancer and CsCaP. Patients with a PIRADS 3 lesion with a PSA density <0.22 can safely avoid prostate biopsy, without a significant risk of missing clinically significant prostate cancer.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/iju.iju_147_23","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T08:31:23Z","timestamp":1696408283000},"page":"297-302","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Prostate cancer detection using magnetic resonance imaging-transrectal ultrasound fusion biopsy: A retrospective cohort study"],"prefix":"10.4103","volume":"39","author":[{"given":"Sarbartha Kumar","family":"Pratihar","sequence":"first","affiliation":[{"name":"Department of Uro Oncology and Robotic Surgery, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Uro Oncology and Robotic Surgery, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Vasudeo","sequence":"additional","affiliation":[{"name":"Department of Uro Oncology and Robotic Surgery, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Venkateshwar Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Saurabh","sequence":"additional","affiliation":[{"name":"Department of Uro Oncology and Robotic Surgery, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuwan","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Uro Oncology and Robotic Surgery, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujahid","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Uro Oncology and Robotic Surgery, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravika S.","family":"Akotkar","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir Kumar","family":"Rawal","sequence":"additional","affiliation":[{"name":"Department of Uro Oncology and Robotic Surgery, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Uro Oncology and Robotic Surgery, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"R1-20240903","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bju.13247","article-title":"The value of magnetic resonance imaging and ultrasonography (MRI\/US)-fusion biopsy platforms in prostate cancer detection: A systematic review","volume":"117","author":"Gayet","year":"2016","journal-title":"BJU Int"},{"key":"R2-20240903","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"key":"R3-20240903","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1148\/rg.323115053","article-title":"Imaging-guided prostate biopsy: Conventional and emerging techniques","volume":"32","author":"Yacoub","year":"2012","journal-title":"Radiographics"},{"key":"R4-20240903","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1464-410X.2009.08938.x","article-title":"'Prostatic evasive anterior tumours': The role of magnetic resonance imaging","volume":"105","author":"Lawrentschuk","year":"2010","journal-title":"BJU Int"},{"key":"R5-20240903","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.eururo.2019.07.014","article-title":"Re: EAU guidelines: Prostate cancer 2019","volume":"76","author":"Sighinolfi","year":"2019","journal-title":"Eur Urol"},{"key":"R6-20240903","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.juro.2017.04.101","article-title":"AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer","volume":"198","author":"Fulgham","year":"2017","journal-title":"J Urol"},{"key":"R7-20240903","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000477214","article-title":"A prospective comparison of selective multiparametric magnetic resonance imaging fusion-targeted and systematic transrectal ultrasound-guided biopsies for detecting prostate cancer in men undergoing repeated biopsies","volume":"99","author":"Boesen","year":"2017","journal-title":"Urol Int"},{"key":"R8-20240903","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.urology.2016.02.041","article-title":"Diagnostic value of guided biopsies: Fusion and cognitive-registration magnetic resonance imaging versus conventional ultrasound biopsy of the prostate","volume":"92","author":"Oberlin","year":"2016","journal-title":"Urology"},{"key":"R9-20240903","first-page":"CD012663","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-20240903","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): A prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"key":"R11-20240903","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"key":"R12-20240903","doi-asserted-by":"crossref","first-page":"298.e1","DOI":"10.1016\/j.urolonc.2019.01.005","article-title":"The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsy","volume":"37","author":"Mannaerts","year":"2019","journal-title":"Urol Oncol"},{"key":"R13-20240903","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4103\/0970-1591.203414","article-title":"Multiparametric magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy: A prospective, single centre study","volume":"33","author":"Bansal","year":"2017","journal-title":"Indian J Urol"},{"key":"R14-20240903","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4111\/icu.2019.60.3.156","article-title":"Multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsies increase the rate of cancer detection in populations with a low incidence of prostate cancer","volume":"60","author":"Kaushal","year":"2019","journal-title":"Investig Clin Urol"},{"key":"R15-20240903","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging \u2013Reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"R16-20240903","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: Definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R17-20240903","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/iju.iju_222_21","article-title":"Safety and feasibility of freehand transperineal prostate biopsy under local anesthesia: Our initial experience","volume":"38","author":"Sivaraman","year":"2022","journal-title":"Indian J Urol"},{"key":"R18-20240903","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","article-title":"Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-na\u00efve men with elevated prostate-specific antigen: A large prospective multicenter clinical study","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"R19-20240903","doi-asserted-by":"crossref","first-page":"e684","DOI":"10.1016\/j.clgc.2020.04.001","article-title":"Negative biopsy histology in men with PI-RADS score 5 in daily clinical practice: Incidence of granulomatous prostatitis","volume":"18","author":"Pepe","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"R20-20240903","doi-asserted-by":"crossref","first-page":"W218","DOI":"10.2214\/AJR.17.18680","article-title":"MRI-ultrasound fusion targeted biopsy of prostate imaging reporting and data system version 2 category 5 lesions found false-positive at multiparametric prostate MRI","volume":"210","author":"Sheridan","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"R21-20240903","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bju.15277","article-title":"Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation","volume":"127","author":"Schoots","year":"2021","journal-title":"BJU Int"},{"key":"R22-20240903","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.euf.2019.06.014","article-title":"Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer: A systematic review and meta-analysis","volume":"6","author":"Maggi","year":"2020","journal-title":"Eur Urol Focus"},{"key":"R23-20240903","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euo.2018.09.001","article-title":"Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7-10 prostate cancer in biopsy-na\u00efve men","volume":"2","author":"Boesen","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"R24-20240903","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.euo.2019.08.015","article-title":"Avoiding unnecessary magnetic resonance imaging (MRI) and biopsies: Negative and positive predictive value of MRI according to prostate-specific antigen density, 4Kscore and risk calculators","volume":"3","author":"Falagario","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"R25-20240903","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.euo.2019.08.008","article-title":"Prebiopsy IMPROD biparametric magnetic resonance imaging combined with prostate-specific antigen density in the diagnosis of prostate cancer: An external validation study","volume":"3","author":"Knaapila","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"R26-20240903","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/cancers14102374","article-title":"Comparative analysis of PSA density and an MRI-based predictive model to improve the selection of candidates for prostate biopsy","volume":"14","author":"Morote","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R27-20240903","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/bju.13465","article-title":"Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy na\u00efve patients","volume":"119","author":"Washino","year":"2017","journal-title":"BJU Int"},{"key":"R28-20240903","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.eururo.2016.08.041","article-title":"Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: Results from a randomized prospective study in biopsy-na\u00efve patients with suspected prostate cancer","volume":"72","author":"Porpiglia","year":"2017","journal-title":"Eur Urol"},{"key":"R29-20240903","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12894-016-0185-z","article-title":"Comparison of the complications of traditional 12 cores transrectal prostate biopsy with image fusion guided transperineal prostate biopsy","volume":"16","author":"Huang","year":"2016","journal-title":"BMC Urol"},{"key":"R30-20240903","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.euo.2019.08.007","article-title":"Complications and adverse events of three magnetic resonance imaging-based target biopsy techniques in the diagnosis of prostate cancer among men with prior negative biopsies: Results from the FUTURE trial, a multicentre randomised controlled trial","volume":"2","author":"Wegelin","year":"2019","journal-title":"Eur Urol Oncol"}],"container-title":["Indian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/iju.iju_147_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:17:00Z","timestamp":1787167020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/iju.iju_147_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/iju.iju_147_23","relation":{},"ISSN":["0970-1591","1998-3824"],"issn-type":[{"value":"0970-1591","type":"print"},{"value":"1998-3824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"assertion":[{"value":"2023-04-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}